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ABSTRACT 
Background Clinicians hesitate to engage with advance care planning (ACP) in heart 
failure. We aimed to identify the disease specific barriers and facilitators for clinicians 
to engage with ACP.
Methods We searched Medline, Embase, CINAHL, PubMed, Scopus, the British 
Nursing Index, the Cochrane Library, the EPOC register, ERIC, PsycINFO, the 
Science Citation Index, and the Grey Literature from inception to July 2018. We 
conducted the review according to ENTREQ guidelines. Two reviewers 
independently assessed original and empirical studies according to CASP criteria. The 
SURE framework and thematic analysis were used to identify barriers and facilitators.
Results Of 2308 articles screened, we reviewed the full text of 42 studies. 17 studies 
were included. The main barriers were lack of disease-specific knowledge about 
palliative care in heart failure, high emotional impact on clinicians when undertaking 
ACP, and lack of multidisciplinary collaboration between healthcare professionals in 
order to reach consensus on when ACP is indicated. The main facilitators were being 
competent to provide holistic care when using ACP in heart failure, a patient taking 
the initiative of having an ACP conversation, and having the resources to deliver ACP 
at a time and place appropriate for the patient.
Conclusions. Training healthcare professionals in the delivery of ACP in heart failure 
might be as important as enabling patients to start an ACP conversation. This two-
fold approach may mitigate against the high emotional impact of ACP. Complex 
interventions are needed to support clinicians as well as patients to engage with ACP.
Key words: Heart failure, advance care planning, barriers, facilitators, clinicians, 
systematic literature review
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BACKGROUND
To be better prepared in the event of a health crisis, conversations about care choices 
and future care planning in heart failure are widely recommended1-3. Advance care 
planning (ACP) is known to facilitate these conversations4, 5 and may improve end of 
life (EOL) care outcomes6, 7. But a number of studies have shown that clinicians are 
hesitant to engage with ACP in clinical practice8, 9. Only the minority of eligible 
patients were given the opportunity of having these conversations10. As a result, 
patient care in heart failure is affected4. Only 37% of patients with end-stage heart 
failure were aware of a poor prognosis, merely 8% of patients and 44% of family 
members were told by clinicians that time was short, and 36% of these patients died 
alone11. The barriers and facilitators for clinicians to engage with ACP in heart failure 
have not been systematically evaluated. 
Past reviews looked at barriers to ACP or conversations in heart failure, but no review 
had rigorously assessed the qualitative evidence base for barriers and facilitators to 
engage clinicians with ACP in heart failure. Lund et al’s12 systematic review 
investigated the barriers and facilitators to the implementation of ACP focussing on 
their workability and integration in clinical practice. However, their review did not 
concentrate on heart failure and addressed only to some extent the barriers facing 
clinicians. The review by Barclay et al.13 investigated the literature concerning 
conversations between professionals and patients suffering from heart failure but did 
not focus on barriers to ACP. Momen’s et al.14 narrative synthesis reviewed the extent 
to which there was evidence that conversations with heart failure patients occurred in 
practice and built on findings from Barclay’s work. Similarly, her narrative did not 
focus on barriers to the implementation of ACP. Slort et al.15 identified barriers and 
facilitators for the general practitioner – patient communication in palliative care. 
While some of their findings were relevant to this study, the authors did not focus on 
heart failure or on barriers to the implementation of ACP by clinicians. De Vleminck 
et al.16 did explore perceived factors hindering or helping GPs in engaging with ACP 
but a focus on the disease-specific barriers to heart failure was missing.  A qualitative 
synthesis of the evidence by Smeets et al.17 sought to identify barriers and facilitators 
for optimal care in heart failure from a GP’s perspective. But the study did only 
concentrate on the clinical management aspects of heart failure rather than on what 
might improve clinicians’ behaviour to initiate ACP.  Consequently, a focus on ACP 
was lacking. Hence, the gap in the evidence was an identification of barriers and 
facilitators to the engagement of clinicians with ACP in heart failure.
AIM AND OBJECTIVES
The aim of this study was to conduct an exploratory systematic review of qualitative 
studies investigating the barriers and facilitators to the implementation of ACP by 
clinicians in heart failure.
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The objectives were as follows:
 To identify the barriers and facilitators to the implementation of ACP by 
healthcare professionals in heart failure
 To synthesise the evidence on recommendations on how to engage clinicians 
with ACP in heart failure
METHODS
We conducted the review according to the Enhancing Transparency in Reporting the 
Synthesis of Qualitative Research (ENTREQ) statement18. This included, but was not 
limited to, defining the research aims and objectives, developing a review protocol, 
conducting data base searches, extracting data based on in- and exclusion criteria, 
assessing the methodological quality of studies and synthesising the evidence19, 20.
Inclusion/ Exclusion Criteria
Types of studies
We included studies that used qualitative study designs and reported original and 
empirical study data.  Qualitative methods for data collection were focus groups, 
interviews, observational studies, surveys and document analysis. Studies had to 
address barriers and facilitators for healthcare professionals to engage with ACP in 
heart failure. Barriers and facilitators were defined as predisposing factors described 
by clinicians that either impede or promote their engagement with ACP21. Studies 
describing other terminal illnesses but not heart failure were excluded from the 
primary analysis. Studies that described ACP for people with life-limiting illnesses 
that involved heart failure were included. Editorials and narrative reviews were 
excluded unless they presented original study findings.
Types of participants
Participants included were all healthcare professionals like GPs, primary care nurses, 
palliative care consultants and nurses, cardiologists, heart failure specialist nurses, 
providing EOL care for patients suffering from heart failure. Studies that solely 
focussed on patients without any reference to healthcare providers were excluded 
from the review.
Types of interventions
ACP was defined as a process of formal decision-making that aimed at helping 
patients make decisions about their future care4. As such ACP could provide an 
opportunity for clinicians to clarify a patient’s care preferences in anticipation of 
future loss of mental capacity. This could involve future treatment choices or 
resuscitation options. In this way, ACP was meant to reduce uncertainty about a 
course of action should the clinical status of a patient deteriorate and capacity is lost22. 
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Types of outcome and healthcare setting
We included studies that primarily described the perceptions and experiences of 
healthcare professionals on barriers and facilitators to their engagement with ACP in 
clinical practice. The healthcare setting could be primary care, nursing homes, 
secondary care, hospital or hospices.
Search strategy and data sources
Studies were retrieved through systematic searches of electronic data bases, screening 
reference lists and contacting authors. Together with a specialist health science 
librarian (NR), we searched the following data sources: Medline, Embase, CINAHL, 
PubMed, Scopus, the British Nursing Index, the Cochrane Library, the EPOC register, 
ERIC, PsycINFO, Science Citation Index, and the Grey Literature.  We searched data 
bases from their inception until July 2018. An example of a MEDLINE search 
strategy is provided in Appendix 1. Additionally; we searched the reference lists of 
five reviews12, 13, 15-17 and all potential relevant cross references and records to identify 
any other studies. Where required, we contacted the study authors or experts in the 
field for further information.
Data analysis 
We elected to use a thematic synthesis approach which drew on the methods from 
thematic analysis of primary sources23 and managed these findings with the SURE 
framework24. The SURE framework (Appendix 2) had been validated across a 
number of healthcare sectors as a systematic yet flexible approach to analysing and 
categorising qualitative data to inform healthcare policy25-27.
Selection of studies
Two reviewers (SC, MS) independently assessed titles and abstracts of identified 
studies against inclusion criteria. Full text papers were retrieved if the content was 
potentially relevant to one or both authors. Two authors (MS, SC) evaluated whether 
these studies should be included in the review. Differences between reviewers were 
resolved by discussion. A list of excluded papers with reasons for their exclusion is 
given in Appendix 3.
Data extraction and management
Initially, we extracted the background information on each included study (study 
objectives, study design and methods, participants) and summarized these in tables. 
Following that, we designed a data extraction sheet that was informed by components 
of the SURE framework. Components of the data extraction focussed on barriers and 
facilitators to implementing ACP by clinicians in healthcare systems. We extracted 
data from included studies and mapped them on to the relevant categories of the 
SURE framework.
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Quality assessment
Two authors (MS, SC) independently assessed the quality of included studies by 
using the Critical Appraisal Skills Programme (CASP) quality assessment tool28. We 
used its seven main quality criteria for assessment (Appendix 4). Each criterion was 
assessed with ‘yes’ or ‘no.’ If the study did not present adequate information, the 
rating was ‘no.’ This resulted in a total quality score ranging from 0 to 7 after 
applying equal weights. Individual studies were categorised as high quality (ratings 
from 6 to 7), medium quality (ratings from 4 to 5), and low quality (scores equal or 
lower than 3). We excluded studies of poor quality and resolved differences by 
discussion.
Data synthesis and analysis
Findings were corroborated narratively using a thematic synthesis approach which 
drew on the methods from thematic analysis of primary sources, extending them to 
systematic reviews29. Thematic synthesis was one of a number of methods suggested 
by the Cochrane Qualitative Review Methods Group30 where evidence was likely to 
be largely descriptive as opposed to highly theorised or conceptual. After reading the 
text of each study, we developed ‘descriptive themes.’ We (MS, BW, JM) discussed 
the set of descriptive themes which informed the categories of the SURE framework 
as a pragmatic approach that was designed to inform healthcare policy.
RESULTS
The literature search identified 2308 potentially eligible studies, of these, 17 papers 
were included in the final qualitative synthesis (Figure 1. PRISMA Flow Diagram). 
Most studies (n=11) were conducted in the UK. Two studies were undertaken in 
Australia31, 32, one in Canada33, one in Sweden34, the USA35 and Belgium16. The 
majority of studies (n=13) included clinicians from primary care. A summary of 
included study characteristics is given in Table 1.
Figure 1. PRISMA flow diagram
Page 6 of 51
https://mc.manuscriptcentral.com/bmjspcare
BMJ Supportive & Palliative Care
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Confidential: For Review Only
7
Study ID Country Relevant study objectives: Study Design Participants CASP Quality 
assessment 
(Score)
Barnes (2006)36 UK To explore attitudes of primary care professionals and 
older people toward communication of diagnosis, 
prognosis and symptoms in CHF
Focus groups with HCPs 
and interviews with 
patients
39 GPs, 37 nurses, 2 health visitors, 1 
nursing home manager, 41 patients with 
CHF
High (6)
Bloomer (2013)31 Australia To explore and identify the preparedness and ability of 
nurses to provide end of life care through the patient’s 
dying phase and their families
Focus groups study with  
clinical nursing and 
management staff  
12 nurses from an intensive care unit 
looking after cardiac and surgical 
patients 
High (6)
Boyd (2004)37 UK To identify some barriers and facilitators for clinicians to 
engage in ACP with patients in their last phase of life.
Interviews and focus 
groups with patients, 
carers and clinicians
16 clinicians from primary and 
secondary care, social and palliative 
care specialists
High (7)
Brooks (2017)32 Australia To explore the experiences of physicians and nurses on 
barriers and enablers to providing EOL care
Focus group study 11 physicians and 17 nurses at an 
intensive care unit
High (6)
Close (2013)38 UK To examine the experience of heart failure diagnosis of 
HCPs, nursing home staff and residents
Qualitative interviews 5 GPs, 3 HF nurses, 17 nursing home 
residents
High (6)
De Vleminck (2014)16 Belgium To identify barriers from a GPs perspective to initiating 
ACP and to gain insight into any differences in barriers 
between cancer, CHF and dementia
Five focus groups with 
General Practitioners 
36 General Practitioners looking after 
terminally ill patients
High (6)
Denvir (2014)39 UK To explore the optimal content and design of a trial on 
EOL intervention for advanced heart disease
Community and hospital 
based focus groups and 
interviews
11 Primary and secondary care 
healthcare professionals
High (6)
Fuat (2003)40 UK To ascertain the beliefs and decision-making practices of 
GPs in the heart failure
Focus group study 30 GPs Medium (5)
Glogowska (2015)41 UK To explore perceptions and experiences of HCPs caring 
for patients suffering from HF
Qualitative interview 
study
24 HCPs including GPs, cardiologists,  
geriatricians, HF specialist nurses
High (7)
Hancock (2014)42 UK To explore changes in HCPs views about the diagnosis 
and management of HF
Focus groups and a 
national survey
56 focus group participants (39 GPs, 4 
cardiologists, 6 general physician, 7 HF 
nurses); 514 survey responses
High (7)
Hanratty (2002)43 UK To identify doctors’ perceptions of the need for palliative 
care for heart failure and barriers to change
Focus groups study 34 GPs, cardiologists, geriatricians, 
medical and palliative care doctors
High (6)
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Hayes (2015)33 Canada To identify the potential challenges and opportunities to 
improve care for CHF in the community
Clinician interview series 28 HCPs including 5 GPs, 8 
cardiologists, 8 nurses, and 4 
pharmacists, 3 admin staff
High (7)
Hjelmfors (2014)34 Sweden To describe nurses’ perspective on discussing EOL issues 
and prognosis with CHF patients
National survey 111 heart failure nurses High (6)
Murray (2015)44 UK To document the barriers and facilitators to palliative 
care in the community
European survey Primary care HCPs from 20 European 
nations
High (7)
Ostertag (2008)35 USA To identify concerns about EOLC amongst HCPs and 
members of the community
Interview and focus group 
study
14 primary care physicians, 19 hospice 
staff, 18 nursing home staff, 19 carers
Medium (5)
Selman (2007)45 UK To investigate communication between staff, patients and 
carers on EOL issues for patients suffering from heart 
failure
Semi-structured 
qualitative interviews 
20 patients with CHF, 11 carers, 6 
palliative care clinicians and 6 
cardiology clinicians
High (7)
Seymour (2010)46 UK To identify factors surrounding community nurses’ 
implementation of ACP and nurses educational needs
Six focus group 
discussions and three 
workshops
23 community nurses looking after 
patients affected by a terminal illness
High (7)
Abbreviations CHF: congestive heart failure; EOL: end of life; EOLC: end of life care; GP: General Practitioner; HCP: healthcare professional; HF: heart failure; 
Table 1. Characteristics of included studies
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Methodological quality of studies
Of the 17 papers, we rated 15 as high quality (CASP score 6-7) and two as medium 
quality (CASP score 4-5)35, 40. One study was excluded due to low quality47. The 
CASP quality ratings of the included studies are summarized in Table 2.
CASP question addressed:
Yes = +                     No = o
Study ID 1 2 3 4 5 6 7
Barnes (2006) + + + + + o +
Bloomer (2013) + + + + + + o
Boyd (2004) + + + + + + +
Brooks (2017) + + + + + o +
Close (2013) + + + + + o +
De Vleminck (2014) + + + + + + o
Denvir (2014) + + + + + o +
Fuat (2003) + + + + o + o
Glogowska (2015) + + + + + + +
Hancock (2014) + + + + + + +
Hanratty (2002) + + + + + + o
Hayes (2015) + + + + + + +
Hjelmfors (2014) + + + + o + +
Murray (2015) + + + + + + +
Ostertag (2008) + + + + o o +
Selman (2007) + + + + + + +
Seymour (2010) + + + + + o +
Table 2. CASP quality assessment
Barriers and facilitators
We summarised the factors reported as barriers and facilitators for the engagement of 
clinicians with ACP in heart failure using the SURE framework (Table 3). All 
barriers and facilitators at a clinician level were categorised under a) knowledge and 
skills, b) attitudes regarding ACP’s acceptability, appropriateness and credibility, and 
c) motivation to engage with ACP. 
Page 9 of 51
https://mc.manuscriptcentral.com/bmjspcare
BMJ Supportive & Palliative Care
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Confidential: For Review Only
10
Factors affecting 
implementation 
of ACP
Barriers Facilitators
Knowledge and 
skills
 lack of knowledge about palliative care 
in  heart failure (e.g. the complexity of 
drugs, ICDs, CRTs)16, 31, 36, 37, 40, 42, 44, 45
 lack of knowledge about the legal 
differences between ACP and 
ADtRTs16, 35, 44, 46
 uncertainty about HF prognosis34, 39, 42, 43, 
45
 lack of EOL communication and 
negotiations skills16, 34, 45
 lack of time to start and complete an 
ACP conversation16, 31, 34, 39, 41
 lack of collaboration with other HCPs 
about the patient32, 40
 not remembering to initiate ACP in the 
rush of everyday clinical practice16, 31
 using euphemisms when talking about 
heart failure and the prognosis32, 42, 46
 being competent about palliative care in 
heart failure36, 37, 42, 45
 knowing what ACP is and what it is 
not16, 44, 46
 knowing the legal differences between 
ACP, ADRTs or living wills16, 35, 46
 creating more time by having ACP 
conversations in the context of a home 
visit or by booking double 
appointments32, 34, 42, 46
 being able to engage patients in shared 
decision-making and ACP32, 37, 40, 42
 consultation with other HCPs about next 
steps in EOLC for the patient35, 40
 having some sort of reminder to indicate 
the need to do ACP for a patient16, 46
 being able to clarify what a patient 
wants to know and what a patient does 
not want to know36, 45
Attitudes 
regarding ACP’s 
acceptability, 
appropriateness 
and credibility
 uncertainty about timing of ACP16, 34, 45, 
46
 emotional difficulties of having an ACP 
conversation16, 42, 45
 ACP perceived as admitting defeat or as 
a failure to a medical treatment 
prerogative32, 39
 believing that cardiologists or heart 
failure specialist nurses are better suited 
than GPs because of their expertise16, 38, 
41-43
 believing that GPs are better suited than 
cardiologists because they have a long-
standing relationship with the patient16, 
41
 waiting for the patient to start a 
conversation about EOL issues16, 36, 37
 concerns about the impact of ACP on 
the patient and the family36, 41
 knowing the patient and family to 
identify the appropriate moment to have 
an EOL conversation16, 31
 knowing a patient’s care preferences and 
values34, 36
 being able to provide a range of 
treatment options appropriate to the 
patient’s phase of illness16, 45
 sharing information between primary- 
and secondary healthcare teams to 
identify who is the appropriate HCP to 
have an ACP conversation and when16, 
32, 33, 37-41, 43
 empowering patients to initiate EOL 
conversations with their healthcare 
provider16, 36, 41
Motivation to 
engage with ACP
 not wanting to alarm patients16, 36, 46
 not wanting to destroy hope when 
initiating ACP conversations34, 39, 46
 being afraid of talking about death and 
dying32, 36, 41, 46
 fear of damaging the clinician - patient 
relationship46
 fear of suggesting to patients that HCPs 
give up38 on them when introducing 
ACP39
 lack of human resources discourages 
HCPs to undertake ACP31, 42, 46
 being able to provide holistic end of life 
care33, 36, 37, 39
 knowing that patients want their HCPs 
to be honest with them32, 36, 41
 being able to improve the quality of life 
for patients and their carers when doing 
ACP38, 46
 an opportunity to be open and 
transparent with patients and give them a 
chance to prepare for the end of life32, 46
 increased resources in terms of time and 
staff to undertake ACP and provide 
‘good’ EOLC31, 42
Abbreviations: ACP: advance care planning; ADRTs: advance decisions to refuse treatment; CRT: Cardiac Resynchronization 
Therapy; EOL: end of life; EOLC: end of life care; HCPs: healthcare professionals; HF: heart failure; ICD: implantable 
cardioverter defibrillator;
Table 3. Barriers and facilitators for clinicians to engage with ACP
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Barriers to clinicians
We identified the following key barriers to the engagement of clinicians with ACP in 
heart failure:
 Knowledge and skills 
One common reported barrier for clinicians to engage with ACP in heart failure was a 
lack of heart failure disease-specific knowledge36, 40, 44, 45 which mainly affected 
GPs42, primary care nurses or palliative care staff33. This related predominantly to the 
complexity of available drugs or the use of implantable cardioverter defibrillator 
(ICDs) and cardiac resynchronization therapy (CRT)37,33, 42. Many times, this disease-
specific barrier was aggravated by uncertainty about the prognosis of the illness 
which prevented ACP from taking place34, 36.
Furthermore, healthcare professionals described a lack of knowledge about ACP in 
general33, 46, what ACP should contain or what the legal differences were between 
ACP and advance decisions to refuse treatment (ADRTs)35, 46. This in turn made 
communication about ACP very challenging for clinicians. A number of studies 
described a lack of communication- and negotiation skills in EOLC as a barrier to the 
implementation of ACP32, 46, 48. Euphemisms were seen as a way to avoid talking 
about heart failure as a diagnosis42 as well as the terminal nature of the disease16, 36. 
However, the use of euphemisms was generally not endorsed by healthcare staff32.
 Attitudes regarding ACP’s acceptability, appropriateness and credibility
One attitude emerging as a barrier in implementing ACP by clinicians in heart failure 
was the perception that in doing so a healthcare professional would admit defeat and 
treatment failure34. This was associated with a considerable negative, emotional 
impact45. Similarly, some studies reported that clinicians saw engaging with ACP as a 
setback to any curative treatment effort42, 49. This attitude applied more to 
cardiologists than to primary or palliative care staff40. Another barrier for not 
undertaking ACP was a lack of collaboration between healthcare professionals. 
Cardiologists believed that a GP was better suited to have an ACP conversation due to 
a GP’s long-standing relationship with the patient43. Conversely, some GPs thought 
that the cardiologist was the professional with the content expertise and therefore 
should start ACP38. There was a general lack of communication between the medical 
disciplines on the issue37, 42. Others reported that clinicians waited for the patient to 
initiate these discussions so that they were sure it was the appropriate time to engage 
with ACP46. Underlying that lack of initiative were also fears and concerns of not 
wanting to upset the patient or the family34, 38.
 Motivation to engage with ACP
Not wanting to cause alarm to patients or carers was a key motivational barrier for 
clinicians not to engage with ACP34. They feared that in delivering ACP, healthcare 
professionals would destroy hope37. Another study reported that their own fear of 
talking about death and dying was another reason for not speaking to patients about 
the last phase of life33. Some clinicians feared that starting an ACP discussion would 
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indicate to a patient that they would give up on them and consequently damage their 
doctor-patient relationship46, 49. Another major factor that discouraged clinicians from 
engaging with ACP was a lack of resources37, 38, 40, 44, 46, mainly time, qualified staff38 
and the right opportunity to address such a sensitive topic39. Additional barriers to 
motivation of healthcare professionals to carry out ACP were the competing demands 
of their clinical role. Workloads and stress often prevented some clinicians from 
undertaking ACP in heart failure37, 42.
Facilitators for clinicians
Studies reported a number of significant facilitators to engage clinicians with ACP in 
heart failure:
 Knowledge and skills 
Being competent in managing the complexities of palliative care in heart failure was a 
key factor for clinicians to engage with ACP36, 46. Other studies reported that a robust 
knowledge of drug regimens and the issues surrounding the use of ICDs and CRTs 
boosted a clinician’s confidence to start the ACP process41, 45.  Healthcare 
professionals were also more likely to deliver ACP if they had a good understanding 
about what were the essential criteria of ACP36, 44, 46. This was especially relevant 
when understanding the legal differences between ACP, ADRTs or living wills46.
Essential skills for implementing ACP were reported as being able to identify the 
level of a patient’s need for information36, clarifying a patient’s care preferences and 
values31 or being able to engage a patient in a shared decision-making process on all 
available treatment options32, 37. Study participants described that obtaining or 
maintaining these skills always involved some form of training37, 43, 48. These skills 
were also relevant when introducing the topic of ACP to a patient36, 44, 46. Starting the 
ACP process could happen in the context of an outpatient appointment, a routine 
medication review or after a hospital admission when the patient was in a stable 
medical condition42.
 Attitudes regarding ACP’s acceptability, appropriateness and credibility
Studies reported a number of attitudes that appeared to promote clinicians’ 
engagement with ACP. Some thought that ACP was easier to initiate when they knew 
the patient and family well32. The context of a long-term doctor - patient relationship 
was conducive for a clinician to identify the right place and time to have an EOL 
conversation34, 41. Similarly, the timing for an ACP conversation was seen as 
appropriate when a patient initiated the conversation41. Some clinicians described a 
sense of relief when this occurred46. Additionally, starting the ACP process was 
perceived as being easier when primary- and secondary healthcare teams collaborated 
well and had reached consensus on a patient33, 37, 41, 44.
 Motivation to engage with ACP
One of the key motivations for clinicians to deliver ACP was being able to provide 
good or holistic37 EOL care. Some clinicians thought that ACP was able to improve 
the quality of life for patients and their carers35, 37. ACP  gave clinicians the stimulus 
to be open and transparent35 and created an opportunity to prepare patients for their 
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last phase of their life43. A few studies described that an increase in human resources 
including more staff time and finances were additional motivational factors to deliver 
ACP37, 42, 44. To resolve the lack of time, some healthcare professionals started ACP in 
the context of a home visit37 or by booking a double clinic appointment. Others 
arranged follow-up visits after the initial conversation to address any unresolved 
issues38, 46.
DISCUSSION
This review synthesised the qualitative evidence from 17 primary studies on barriers 
and facilitators to the engagement of clinicians with ACP in heart failure. Systematic 
review methods were based on recommended standards to enhance transparency and 
reporting for qualitative evidence19.
Significant themes for barriers to the engagement of clinicians with ACP in heart 
failure were:
 Lack of disease-specific knowledge about palliative care in heart failure 
 Lack of skills in communicating ACP with a patient suffering from heart 
failure
 Lack of collaboration between healthcare professionals in order to reach 
consensus on when ACP is indicated 
 The high emotional impact on the healthcare professional when undertaking 
ACP 
Important themes for facilitators to help clinicians engage with ACP in heart failure 
were:
 Being competent in the use of ACP and the clinical management of end stage 
heart failure
 Being able to provide holistic EOL care when using ACP 
 Having a trusting and long-term relationship with the patient and carers
 A patient initiating an ACP conversation
 Being able to deliver ACP at a time and place appropriate for the patient
Comparison with existing literature
Several of our findings on barriers and facilitators concurred with those from other 
reviews: the complexity and inherent uncertainty of some aspects of end-stage heart 
failure management17, skills in initiating ACP and communicating EOL issues13, 49 or 
having sufficient resources12 and a functioning network of collaborations between 
medical specialities17 applied to our results as well. Educating and training clinicians 
in the delivery of ACP should help them become more skilled with the process of 
initiating these conversations. Being able to conduct these discussions was seen as 
important, since there were suggestions that supportive or palliative care for heart 
failure patients should be made available at all stages of the disease trajectory50. 
Having these conversations as a normal part of heart failure management was 
balanced by the precaution to adjust the dialogue to a patient’s need for information in 
order to avoid a loss of hope or an increase in anxiety14. This applied particularly to 
patients who did not want to talk about EOL issues or engage with ACP51.  Again, 
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this precaution had to be considered in the context that a number of clinicians avoided 
disclosing the diagnosis of heart failure all together or evaded answering any 
questions about the prognosis of the illness52. But the majority of patients preferred 
open and honest information about their condition while maintaining a sense of 
hope51. So, the training of clinicians in communicating ACP sensitively seemed even 
more important. 
Strengths and limitations
This was the first qualitative synthesis specifically addressing barriers and facilitators 
for engaging clinicians with ACP in heart failure. Several of our findings concurred 
with other reviews. However, the global transferability of our qualitative results may 
be limited since the majority of included studies were based in the UK. Some studies 
included other life-limiting illnesses like cancer or COPD in addition to patients 
suffering from heart failure. Some studies included other life-limiting illnesses like 
cancer or COPD in addition to patients suffering from heart failure. Consequently, our 
findings may have been affected by barriers and facilitators to the implementation of 
ACP that exist in other end-of-life conditions and not just heart failure.
The SURE framework proved to be helpful in facilitating an understanding of the 
barriers and facilitators to the implementation of ACP in the published literature. This 
approach facilitated the synthesise of findings from the thematic analysis in a 
systematic way according to healthcare professionals’ knowledge and skills, their 
attitudes regarding ACP’s acceptability, appropriateness and credibility and their 
motivation to engage with ACP. Once we achieved consensus on the barriers and 
facilitators in included papers, mapping these to the SURE structure was efficient and 
straight forward. 
Conversely, using the SURE framework largely centred the analysis of thematic 
findings on barriers and facilitators to the implementation of ACP by clinicians. This 
approach may have limited the diversity of qualitative data and narrowed the 
complexity of the phenomenon under investigation to factors affecting the 
implementation of the intervention by clinicians. Consequently, there may have been 
a risk that other themes outside the scope of SURE were not sufficiently considered 
like the wider political or cultural context of ACP.
A novel finding from this review suggests that patients may hold the key in engaging 
clinicians with ACP41. Their initiative in starting an ACP conversation might have the 
potential to mitigate against the high emotional impact on healthcare professionals33, 
38. The literature suggests that, for example, question prompt lists (QPLs) have the 
potential to empower patients to initiate EOL conversations with their healthcare 
provider53. If a patient initiates the discussion about ACP in heart failure, clinicians 
may feel less reticent about raising the topic by responding to a patient’s question. A 
number of studies report a small but significant increase in questions by patients about 
diagnosis, prognosis and treatment when a QPL had been used53, 54. Most of these 
studies investigated the effect of QPLs in a cancer setting. Further research for the 
effect of QPLs on patients suffering from heart failure is still outstanding since these 
studies investigated the effect of QPLs in a cancer setting.
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Conclusions and recommendations
This review has shown that clinicians often lack disease-specific knowledge about the 
clinical management of advanced heart failure and the confidence to engage with 
EOL issues and ACP. Available evidence suggests that training clinicians should 
include skills to identify the level of a patient’s need for information, clarifying a 
patient’s care preferences and values and being able to engage a patient in a 
conversation on all available treatment options. There are a number of suggested 
methods to achieve these skills which may include interactive educational meetings 
involving role play preferably facilitated by local opinion leaders and experts in the 
field of heart failure to enhance clinicians’ engagement. 
Based on current findings, training clinicians in the delivery of ACP in heart failure 
might be equally important to assisting patients to start an ACP conversation. This 
two-fold approach may mitigate against the high emotional impact of ACP on 
healthcare professionals. Complex interventions are needed to support both, clinicians 
as well as patients, to engage with ACP in heart failure.
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ABSTRACT 
Background Clinicians hesitate to engage with advance care planning (ACP) in heart 
failure. We aimed to identify the disease specific barriers and facilitators for clinicians 
to engage with ACP.
Methods We searched Medline, Embase, CINAHL, PubMed, Scopus, the British 
Nursing Index, the Cochrane Library, the EPOC register, ERIC, PsycINFO, the 
Science Citation Index, and the Grey Literature from inception to July 2018. We 
conducted the review according to ENTREQ guidelines. Two reviewers 
independently assessed original and empirical studies according to CASP criteria. The 
SURE framework and thematic analysis were used to identify barriers and facilitators.
Results Of 2308 articles screened, we reviewed the full text of 42 studies. 17 studies 
were included. The main barriers were lack of disease-specific knowledge about 
palliative care in heart failure, high emotional impact on clinicians when undertaking 
ACP, and lack of multidisciplinary collaboration between healthcare professionals in 
order to reach consensus on when ACP is indicated. The main facilitators were being 
competent to provide holistic care when using ACP in heart failure, a patient taking 
the initiative of having an ACP conversation, and having the resources to deliver ACP 
at a time and place appropriate for the patient.
Conclusions. Training healthcare professionals in the delivery of ACP in heart failure 
might be as important as enabling patients to start an ACP conversation. This two-
fold approach may mitigate against the high emotional impact of ACP. Complex 
interventions are needed to support clinicians as well as patients to engage with ACP.
Key words: Heart failure, advance care planning, barriers, facilitators, clinicians, 
systematic literature review
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BACKGROUND
To be better prepared in the event of a health crisis, conversations about care choices 
and future care planning in heart failure are widely recommended1-3. Advance care 
planning (ACP) is known to facilitate these conversations4, 5 and may improve end of 
life (EOL) care outcomes6, 7. But a number of studies have shown that clinicians are 
hesitant to engage with ACP in clinical practice8, 9. Only the minority of eligible 
patients were given the opportunity of having these conversations10. As a result, 
patient care in heart failure is aff cted4. Only 37% of patients with end-stage heart 
failure were aware of a poor prognosis, merely 8% of patients and 44% of family 
members were told by clinicians that time was short, and 36% of these patients died 
alone11. The barriers and facilitators for clinicians to engage with ACP in heart failure 
have not been systematically evaluated. 
Past reviews looked at barriers to ACP or conversations in heart failure, but no review 
had rigorously assessed the qualitative evidence base for barriers and facilitators to 
engage clinicians with ACP in heart failure. Lund et al’s12 systematic review 
investigated the barriers and facilitators to the implementation of ACP focussing on 
their workability and integration in clinical practice. However, their review did not 
concentrate on heart failure and addressed only to some extent the barriers facing 
clinicians. The review by Barclay et al.13 investigated the literature concerning 
conversations between professionals and patients suffering from heart failure but did 
not focus on barriers to ACP. Momen’s et al.14 narrative synthesis reviewed the extent 
to which there was evidence that conversations with heart failure patients occurred in 
practice and built on findings from Barclay’s work. Similarly, her narrative did not 
focus on barriers to the implementation of ACP. Slort et al.15 identified barriers and 
facilitators for the general practitioner – patient communication in palliative care. 
While some of their findings were relevant to this study, the authors did not focus on 
heart failure or on barriers to the implementation of ACP by clinicians. De Vleminck 
et al.16 did explore perceived factors hindering or helping GPs in engaging with ACP 
but a focus on the disease-specific barriers to heart failure was missing.  A qualitative 
synthesis of the evidence by Smeets et al.17 sought to identify barriers and facilitators 
for optimal care in heart failure from a GP’s perspective. But the study did only 
concentrate on the clinical management aspects of heart failure rather than on what 
might improve clinicians’ behaviour to initiate ACP.  Consequently, a focus on ACP 
was lacking. Hence, the gap in the evidence was an identification of barriers and 
facilitators to the engagement of clinicians with ACP in heart failure.
AIM AND OBJECTIVES
The aim of this study was to conduct an exploratory systematic review of qualitative 
studies investigating the barriers and facilitators to the implementation of ACP by 
clinicians in heart failure.
Commented [MS3]:  The reference has been updated from a 
more recent paper i.e. Adler et al. (2009)
Page 25 of 51
https://mc.manuscriptcentral.com/bmjspcare
BMJ Supportive & Palliative Care
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Confidential: For Review Only
4
The objectives were as follows:
 To identify the barriers and facilitators to the implementation of ACP by 
healthcare professionals in heart failure
 To synthesise the evidence on recommendations on how to engage clinicians 
with ACP in heart failure
METHODS
We conducted the review according to the Enhancing Transparency in Reporting the 
Synthesis of Qualitative Research (ENTREQ) statement18. This included, but was not 
limited to, defining the research aims and objectives, developing a review protocol, 
conducting data base searches, extracting data based on in- and exclusion criteria, 
assessing the methodological quality of studies and synthesising the evidence19, 20.
Inclusion/ Exclusion Criteria
Types of studies
We included studies that used qualitative study designs and reported original and 
empirical study data.  Qualitative methods for data collection were focus groups, 
interviews, observational studies, surveys and document analysis. Studies had to 
address barriers and facilitators for healthcare professionals to engage with ACP in 
heart failure. Barriers and facilitators were defined as predisposing factors described 
by clinicians that either impede or promote their engagement with ACP21. Studies 
describing other terminal illnesses but not heart failure were excluded from the 
primary analysis. Studies that described ACP for people with life-limiting illnesses 
that involved heart failure were included. Editorials and narrative reviews were 
excluded unless they presented original study findings.
Types of participants
Participants included were all healthcare professionals like GPs, primary care nurses, 
palliative care consultants and nurses, cardiologists, heart failure specialist nurses, 
providing EOL care for patients suffering from heart failure. Studies that solely 
focussed on patients without any reference to healthcare providers were excluded 
from the review.
Types of interventions
ACP was defined as a process of formal decision-making that aimed at helping 
patients make decisions about their future care4. As such ACP could provide an 
opportunity for clinicians to clarify a patient’s care preferences in anticipation of 
future loss of mental capacity. This could involve future treatment choices or 
resuscitation options. In this way, ACP was meant to reduce uncertainty about a 
course of action should the clinical status of a patient deteriorate and capacity is lost22. 
Commented [MS4]:  We have clarified that we have 
included studies that involved other life-limiting illnesses if 
they included heart failure. We have discussed this as a 
limitation in the discussion section which states:
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Types of outcome and healthcare setting
We included studies that primarily described the perceptions and experiences of 
healthcare professionals on barriers and facilitators to their engagement with ACP in 
clinical practice. The healthcare setting could be primary care, nursing homes, 
secondary care, hospital or hospices.
Search strategy and data sources
Studies were retrieved through systematic searches of electronic data bases, screening 
reference lists and contacting authors. Together with a specialist health science 
librarian (NR), we searched the following data sources: Medline, Embase, CINAHL, 
PubMed, Scopus, the British Nursing Index, the Cochrane Library, the EPOC register, 
ERIC, PsycINFO, Science Citation Index, and the Grey Literature.  We searched data 
bases from their inception until July 2018. An example of a MEDLINE search 
strategy is provided in Appendix 1. Additionally; we searched the reference lists of 
five reviews12, 13, 15-17 and all potential relevant cross references and records to identify 
any other studies. Where required, we contacted the study authors or experts in the 
field for further information.
Data analysis 
We elected to use a thematic synthesis approach which drew on the methods from 
thematic analysis of primary sources23 and managed these findings with the SURE 
framework24. The SURE framework (Appendix 2) had been validated across a 
number of healthcare sectors as a systematic yet flexible approach to analysing and 
categorising qualitative data to inform healthcare policy25-27.
Selection of studies
Two reviewers (SC, MS) independently assessed titles and abstracts of identified 
studies against inclusion criteria. Full text papers were retrieved if the content was 
potentially relevant to one or both authors. Two authors (MS, SC) evaluated whether 
these studies should be included in the review. Differences between reviewers were 
resolved by discussion. A list of excluded papers with reasons for their exclusion is 
given in Appendix 3.
Data extraction and management
Initially, we extracted the background information on each included study (study 
objectives, study design and methods, participants) and summarized these in tables. 
Following that, we designed a data extraction sheet that was informed by components 
of the SURE framework. Components of the data extraction focussed on barriers and 
facilitators to implementing ACP by clinicians in healthcare systems. We extracted 
data from included studies and mapped them on to the relevant categories of the 
SURE framework.
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Quality assessment
Two authors (MS, SC) independently assessed the quality of included studies by 
using the Critical Appraisal Skills Programme (CASP) quality assessment tool28. We 
used its seven main quality criteria for assessment (Appendix 4). Each criterion was 
assessed with ‘yes’ or ‘no.’ If the study did not present adequate information, the 
rating was ‘no.’ This resulted in a total quality score ranging from 0 to 7 after 
applying equal weights. Individual studies were categorised as high quality (ratings 
from 6 to 7), medium quality (ratings from 4 to 5), and low quality (scores equal or 
lower than 3). We excluded studies of poor quality and resolved differences by 
discussion.
Data synthesis and analysis
Findings were corroborated narratively using a thematic synthesis approach which 
drew on the methods from thematic analysis of primary sources, extending them to 
systematic reviews29. Thematic synthesis was one of a number of methods suggested 
by the Cochrane Qualitative Review Methods Group30 where evidence was likely to 
be largely descriptive as opposed to highly theorised or conceptual. After reading the 
text of each study, we developed ‘descriptive themes.’ We (MS, BW, JIM) discussed 
the set of descriptive themes which informed the categories of the SURE framework 
as a pragmatic approach that was designed to inform healthcare policy.
RESULTS
The literature search identified 2308 potentially eligible studies, of these, 17 papers 
were included in the final qualitative synthesis (Figure 1. PRISMA Flow Diagram). 
Most studies (n=11) were conducted in the UK. Two studies were undertaken in 
Australia31, 32, one in Canada33, one in Sweden34, the USA35 and Belgium16. The 
majority of studies (n=13) included clinicians from primary care. A summary of 
included study characteristics is given in Table 1.
Figure 1. PRISMA flow diagram Commented [MS5]:  We have used the original PRISMA 
diagram (see Figure 1) and have updated our results.
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Study ID Country Relevant study objectives: Study Design Participants CASP Quality 
assessment 
(Score)
Barnes (2006)36 UK To explore attitudes of primary care professionals and 
older people toward communication of diagnosis, 
prognosis and symptoms in CHF
Focus groups with HCPs 
and interviews with 
patients
39 GPs, 37 nurses, 2 health visitors, 1 
nursing home manager, 41 patients with 
CHF
High (6)
Bloomer (2013)31 Australia To explore and identify the preparedness and ability of 
nurses to provide end of life care through the patient’s 
dying phase and their families
Focus groups study with  
clinical nursing and 
management staff  
12 nurses from an intensive care unit 
looking after cardiac and surgical 
patients 
High (6)
Boyd (2004)37 UK To identify some barriers and facilitators for clinicians to 
engage in ACP with patients in their last phase of life.
Interviews and focus 
groups with patients, 
carers and clinicians
16 clinicians from primary and 
secondary care, social and palliative 
care specialists
High (7)
Brooks (2017)32 Australia To explore the experiences of physicians and nurses on 
barriers and enablers to providing EOL care
Focus group study 11 physicians and 17 nurses at an 
intensive care unit
High (6)
Close (2013)38 UK To examine the experience of heart failure diagnosis of 
HCPs, nursing home staff and residents
Qualitative interviews 5 GPs, 3 HF nurses, 17 nursing home 
residents
High (6)
De Vleminck (2014)16 Belgium To identify barriers from a GPs perspective to initiating 
ACP and to gain insight into any differences in barriers 
between cancer, CHF and dementia
Five focus groups with 
General Practitioners 
36 General Practitioners looking after 
terminally ill patients
High (6)
Denvir (2014)39 UK To explore the optimal content and design of a trial on 
EOL intervention for advanced heart disease
Community and hospital 
based focus groups and 
interviews
11 Primary and secondary care 
healthcare professionals
High (6)
Fuat (2003)40 UK To ascertain the beliefs and decision-making practices of 
GPs in the heart failure
Focus group study 30 GPs Medium (5)
Glogowska (2015)41 UK To explore perceptions and experiences of HCPs caring 
for patients suffering from HF
Qualitative interview 
study
24 HCPs including GPs, cardiologists,  
geriatricians, HF specialist nurses
High (7)
Hancock (2014)42 UK To explore changes in HCPs views about the diagnosis 
and management of HF
Focus groups and a 
national survey
56 focus group participants (39 GPs, 4 
cardiologists, 6 general physician, 7 HF 
nurses); 514 survey responses
High (7)
Hanratty (2002)43 UK To identify doctors’ perceptions of the need for palliative 
care for heart failure and barriers to change
Focus groups study 34 GPs, cardiologists, geriatricians, 
medical and palliative care doctors
High (6)
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Hayes (2015)33 Canada To identify the potential challenges and opportunities to 
improve care for CHF in the community
Clinician interview series 28 HCPs including 5 GPs, 8 
cardiologists, 8 nurses, and 4 
pharmacists, 3 admin staff
High (7)
Hjelmfors (2014)34 Sweden To describe nurses’ perspective on discussing EOL issues 
and prognosis with CHF patients
National survey 111 heart failure nurses High (6)
Murray (2015)44 UK To document the barriers and facilitators to palliative 
care in the community
European survey Primary care HCPs from 20 European 
nations
High (7)
Ostertag (2008)35 USA To identify concerns about EOLC amongst HCPs and 
members of the community
Interview and focus group 
study
14 primary care physicians, 19 hospice 
staff, 18 nursing home staff, 19 carers
Medium (5)
Selman (2007)45 UK To investigate communication between staff, patients and 
carers on EOL issues for patients suffering from heart 
failure
Semi-structured 
qualitative interviews 
20 patients with CHF, 11 carers, 6 
palliative care clinicians and 6 
cardiology clinicians
High (7)
Seymour (2010)46 UK To identify factors surrounding community nurses’ 
implementation of ACP and nurses educational needs
Six focus group 
discussions and three 
workshops
23 community nurses looking after 
patients affected by a terminal illness
High (7)
Abbreviations CHF: congestive heart failure; EOL: end of life; EOLC: end of life care; GP: General Practitioner; HCP: healthcare professional; HF: heart failure; 
Table 1. Characteristics of included studies
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Methodological quality of studies
Of the 17 papers, we rated 15 as high quality (CASP score 6-7) and two as medium 
quality (CASP score 4-5)35, 40. One study was excluded due to low quality47. The 
CASP quality ratings of the included studies are summarized in Table 2.
CASP question addressed:
Yes = +                     No = o
Study ID 1 2 3 4 5 6 7
Barnes (2006) + + + + + o +
Bloomer (2013) + + + + + + o
Boyd (2004) + + + + + + +
Brooks (2017) + + + + + o +
Close (2013) + + + + + o +
De Vleminck (2014) + + + + + + o
Denvir (2014) + + + + + o +
Fuat (2003) + + + + o + o
Glogowska (2015) + + + + + + +
Hancock (2014) + + + + + + +
Hanratty (2002) + + + + + + o
Hayes (2015) + + + + + + +
Hjelmfors (2014) + + + + o + +
Murray (2015) + + + + + + +
Ostertag (2008) + + + + o o +
Selman (2007) + + + + + + +
Seymour (2010) + + + + + o +
Table 2. CASP quality assessment
Barriers and facilitators
We summarised the factors reported as barriers and facilitators for the engagement of 
clinicians with ACP in heart failure using the SURE framework (Table 3). All 
barriers and facilitators at a clinician level were categorised under a) knowledge and 
skills, b) attitudes regarding ACP’s acceptability, appropriateness and credibility, and 
c) motivation to engage with ACP. 
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Factors affecting 
implementation 
of ACP
Barriers Facilitators
Knowledge and 
skills
 lack of knowledge about palliative care 
in  heart failure (e.g. the complexity of 
drugs, ICDs, CRTs)16, 31, 36, 37, 40, 42, 44, 45
 lack of knowledge about the legal 
differences between ACP and 
ADtRTs16, 35, 44, 46
 uncertainty about HF prognosis34, 39, 42, 43, 
45
 lack of EOL communication and 
negotiations skills16, 34, 45
 lack of time to start and complete an 
ACP conversation16, 31, 34, 39, 41
 lack of collaboration with other HCPs 
about the patient32, 40
 not remembering to initiate ACP in the 
rush of everyday clinical practice16, 31
 using euphemisms when talking about 
heart failure and the prognosis32, 42, 46
 being competent about palliative care in 
heart failure36, 37, 42, 45
 knowing what ACP is and what it is 
not16, 44, 46
 knowing the legal differences between 
ACP, ADRTs or living wills16, 35, 46
 creating more time by having ACP 
conversations in the context of a home 
visit or by booking double 
appointments32, 34, 42, 46
 being able to engage patients in shared 
decision-making and ACP32, 37, 40, 42
 consultation with other HCPs about next 
steps in EOLC for the patient35, 40
 having some sort of reminder to indicate 
the need to do ACP for a patient16, 46
 being able to clarify what a patient 
wants to know and what a patient does 
not want to know36, 45
Attitudes 
regarding ACP’s 
acceptability, 
appropriateness 
and credibility
 uncertainty about timing of ACP16, 34, 45, 
46
 emotional difficulties of having an ACP 
conversation16, 42, 45
 ACP perceived as admitting defeat or as 
a failure to a medical treatment 
prerogative32, 39
 believing that cardiologists or heart 
failure specialist nurses are better suited 
than GPs because of their expertise16, 38, 
41-43
 believing that GPs are better suited than 
cardiologists because they have a long-
standing relationship with the patient16, 
41
 waiting for the patient to start a 
conversation about EOL issues16, 36, 37
 concerns about the impact of ACP on 
the patient and the family36, 41
 knowing the patient and family to 
identify the appropriate moment to have 
an EOL conversation16, 31
 knowing a patient’s care preferences and 
values34, 36
 being able to provide a range of 
treatment options appropriate to the 
patient’s phase of illness16, 45
 sharing information between primary- 
and secondary healthcare teams to 
identify who is the appropriate HCP to 
have an ACP conversation and when16, 
32, 33, 37-41, 43
 empowering patients to initiate EOL 
conversations with their healthcare 
provider16, 36, 41
Motivation to 
engage with ACP
 not wanting to alarm patients16, 36, 46
 not wanting to destroy hope when 
initiating ACP conversations34, 39, 46
 being afraid of talking about death and 
dying32, 36, 41, 46
 fear of damaging the clinician - patient 
relationship46
 fear of suggesting to patients that HCPs 
give up38 on them when introducing 
ACP39
 lack of human resources discourages 
HCPs to undertake ACP31, 42, 46
 being able to provide holistic end of life 
care33, 36, 37, 39
 knowing that patients want their HCPs 
to be honest with them32, 36, 41
 being able to improve the quality of life 
for patients and their carers when doing 
ACP38, 46
 an opportunity to be open and 
transparent with patients and give them a 
chance to prepare for the end of life32, 46
 increased resources in terms of time and 
staff to undertake ACP and provide 
‘good’ EOLC31, 42
Abbreviations: ACP: advance care planning; ADRTs: advance decisions to refuse treatment; CRT: Cardiac Resynchronization 
Therapy; EOL: end of life; EOLC: end of life care; HCPs: healthcare professionals; HF: heart failure; ICD: implantable 
cardioverter defibrillator;
Table 3. Barriers and facilitators for clinicians to engage with ACP
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Barriers to clinicians
We identified the following key barriers to the engagement of clinicians with ACP in 
heart failure:
 Knowledge and skills 
One common reported barrier for clinicians to engage with ACP in heart failure was a 
lack of heart failure disease-specific knowledge36, 40, 44, 45 which mainly affected 
GPs42, primary care nurses or palliative care staff33. This related predominantly to the 
complexity of available drugs or the use of implantable cardioverter defibrillator 
(ICDs) and cardiac resynchronization therapy (CRT)37,33, 42. Many times, this disease-
specific barrier was aggravated by uncertainty about the prognosis of the illness 
which prevented ACP from taking place34, 36.
Furthermore, healthcare professionals described a lack of knowledge about ACP in 
general33, 46, what ACP should contain or what the legal differences were between 
ACP and advance decisions to refuse treatment (ADRTs)35, 46. This in turn made 
communication about ACP very challenging for clinicians. A number of studies 
described a lack of communication- and negotiation skills in EOLC as a barrier to the 
implementation of ACP32, 46, 48. Euphemisms were seen as a way to avoid talking 
about heart failure as a diagnosis42 as well as the terminal nature of the disease16, 36. 
However, the use of euphemisms was generally not endorsed by healthcare staff32.
 Attitudes regarding ACP’s acceptability, appropriateness and credibility
One attitude emerging as a barrier in implementing ACP by clinicians in heart failure 
was the perception that in doing so a healthcare professional would admit defeat and 
treatment failure34. This was associated with a considerable negative, emotional 
impact45. Similarly, some studies reported that clinicians saw engaging with ACP as a 
setback to any curative treatment effort42, 49. This attitude applied more to 
cardiologists than to primary or palliative care staff40. Another barrier for not 
undertaking ACP was a lack of collaboration between healthcare professionals. 
Cardiologists believed that a GP was better suited to have an ACP conversation due to 
a GP’s long-standing relationship with the patient43. Conversely, some GPs thought 
that the cardiologist was the professional with the content expertise and therefore 
should start ACP38. There was a general lack of communication between the medical 
disciplines on the issue37, 42. Others reported that clinicians waited for the patient to 
initiate these discussions so that they were sure it was the appropriate time to engage 
with ACP46. Underlying that lack of initiative were also fears and concerns of not 
wanting to upset the patient or the family34, 38.
 Motivation to engage with ACP
Not wanting to cause alarm to patients or carers was a key motivational barrier for 
clinicians not to engage with ACP34. They feared that in delivering ACP, healthcare 
professionals would destroy hope37. Another study reported that their own fear of 
talking about death and dying was another reason for not speaking to patients about 
the last phase of life33. Some clinicians feared that starting an ACP discussion would 
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indicate to a patient that they would give up on them and consequently damage their 
doctor-patient relationship46, 49. Another major factor that discouraged clinicians from 
engaging with ACP was a lack of resources37, 38, 40, 44, 46, mainly time, qualified staff38 
and the right opportunity to address such a sensitive topic39. Additional barriers to 
motivation of healthcare professionals to carry out ACP were the competing demands 
of their clinical role. Workloads and stress often prevented some clinicians from 
undertaking ACP in heart failure37, 42.
Facilitators for clinicians
Studies reported a number of significant facilitators to engage clinicians with ACP in 
heart failure:
 Knowledge and skills 
Being competent in managing the complexities of palliative care in heart failure was a 
key factor for clinicians to engage with ACP36, 46. Other studies reported that a robust 
knowledge of drug regimens and the issues surrounding the use of ICDs and CRTs 
boosted a clinician’s confidence to start the ACP process41, 45.  Healthcare 
professionals were also more likely to deliver ACP if they had a good understanding 
about what were the essential criteria of ACP36, 44, 46. This was especially relevant 
when understanding the legal differences between ACP, ADRTs or living wills46.
Essential skills for implementing ACP were reported as being able to identify the 
level of a patient’s need for information36, clarifying a patient’s care preferences and 
values31 or being able to engage a patient in a shared decision-making process on all 
available treatment options32, 37. Study participants described that obtaining or 
maintaining these skills always involved some form of training37, 43, 48. These skills 
were also relevant when introducing the topic of ACP to a patient36, 44, 46. Starting the 
ACP process could happen in the context of an outpatient appointment, a routine 
medication review or after a hospital admission when the patient was in a stable 
medical condition42.
 Attitudes regarding ACP’s acceptability, appropriateness and credibility
Studies reported a number of attitudes that appeared to promote clinicians’ 
engagement with ACP. Some thought that ACP was easier to initiate when they knew 
the patient and family well32. The context of a long-term doctor - patient relationship 
was conducive for a clinician to identify the right place and time to have an EOL 
conversation34, 41. Similarly, the timing for an ACP conversation was seen as 
appropriate when a patient initiated the conversation41. Some clinicians described a 
sense of relief when this occurred46. Additionally, starting the ACP process was 
perceived as being easier when primary- and secondary healthcare teams collaborated 
well and had reached consensus on a patient33, 37, 41, 44.
 Motivation to engage with ACP
One of the key motivations for clinicians to deliver ACP was being able to provide 
good or holistic37 EOL care. Some clinicians thought that ACP was able to improve 
the quality of life for patients and their carers35, 37. ACP  gave clinicians the stimulus 
to be open and transparent35 and created an opportunity to prepare patients for their 
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last phase of their life43. A few studies described that an increase in human resources 
including more staff time and finances were additional motivational factors to deliver 
ACP37, 42, 44. To resolve the lack of time, some healthcare professionals started ACP in 
the context of a home visit37 or by booking a double clinic appointment. Others 
arranged follow-up visits after the initial conversation to address any unresolved 
issues38, 46.
DISCUSSION
This review synthesised the qualitative evidence from 17 primary studies on barriers 
and facilitators to the engagement of clinicians with ACP in heart failure. Systematic 
review methods were based on recommended standards to enhance transparency and 
reporting for qualitative evidenc 19.
Significant themes for barriers to the engagement of clinicians with ACP in heart 
failure were:
 Lack of disease-specific knowledge about palliative care in heart failure 
 Lack of skills in communicating ACP with a patient suffering from heart 
failure
 Lack of collaboration between healthcare professionals in order to reach 
consensus on when ACP is indicated 
 The high emotional impact on the healthcare professional when undertaking 
ACP 
Important themes for facilitators to help clinicians engage with ACP in heart failure 
were:
 Being competent in the use of ACP and the clinical management of end stage 
heart failure
 Being able to provide holistic EOL care when using ACP 
 Having a trusting and long-term relationship with the patient and carers
 A patient initiating an ACP conversation
 Being able to deliver ACP at a time and place appropriate for the patient
Comparison with existing literature
Several of our findings on barriers and facilitators concurred with those from other 
reviews: the complexity and inherent uncertainty of some aspects of end-stage heart 
failure management17, skills in initiating ACP and communicating EOL issues13, 49 or 
having sufficient resources12 and a functioning network of collaborations between 
medical specialities17 applied to our results as well. Educating and training clinicians 
in the delivery of ACP should help them become more skilled with the process of 
initiating these conversations. Being able to conduct these discussions was seen as 
important, since there were suggestions that supportive or palliative care for heart 
failure patients should be made available at all stages of the disease trajectory50. 
Having these conversations as a normal part of heart failure management was 
balanced by the precaution to adjust the dialogue to a patient’s need for information in 
order to avoid a loss of hope or an increase in anxiety14. This applied particularly to 
patients who did not want to talk about EOL issues or engage with ACP51.  Again, 
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this precaution had to be considered in the context that a number of clinicians avoided 
disclosing the diagnosis of heart failure all together or evaded answering any 
questions about the prognosis of the illness52. But the majority of patients preferred 
open and honest information about their condition while maintaining a sense of 
hope51. So, the training of clinicians in communicating ACP sensitively seemed even 
more important. 
Strengths and limitations
This was the first qualitative synthesis specifically addressing barriers and facilitators 
for engaging clinicians with ACP in heart failure. Several of our findings concurred 
with other reviews. However, the global transferability of our qualitative results may 
be limited since the majority of included studies were based in the UK. Some studies 
included other life-limiting illnesses like cancer or COPD in addition to patients 
suffering from heart failure. Some studies included other life-limiting illnesses like 
cancer or COPD in addition to patients suffering from heart failure. Consequently, our 
findings may have been affected by barriers and facilitators to the implementation of 
ACP that exist in other end-of-life conditions and not just heart failure.
The SURE framework proved to be helpful in facilitating an understanding of the 
barriers and facilitators to the implementation of ACP in the published literature. This 
approach facilitated the synthesise of findings from the thematic analysis in a 
systematic way according to healthcare professionals’ knowledge and skills, their 
attitudes regarding ACP’s acceptability, appropriateness and credibility and their 
motivation to engage with ACP. Once we achieved consensus on the barriers and 
facilitators in included papers, mapping these to the SURE structure was efficient and 
straight forward. 
Conversely, using the SURE framework largely centred the analysis of thematic 
findings on barriers and facilitators to the implementation of ACP by clinicians. This 
approach may have limited the diversity of qualitative data and narrowed the 
complexity of the phenomenon under investigation to factors affecting the 
implementation of the intervention by clinicians. Consequently, there may have been 
a risk that other themes outside the scope of SURE were not sufficiently considered 
like the wider political or cultural context of ACP.
A novel finding from this review suggests that patients may hold the key in engaging 
clinicians with ACP41. Their initiative in starting an ACP conversation might have the 
potential to mitigate against the high emotional impact on healthcare professionals33, 
38. The literature suggests that, for example, question prompt lists (QPLs) have the 
potential to empower patients to initiate EOL conversations with their healthcare 
provider53. If a patient initiates the discussion about ACP in heart failure, clinicians 
may feel less reticent about raising the topic by responding to a patient’s question. A 
number of studies report a small but significant increase in questions by patients about 
diagnosis, prognosis and treatment when a QPL had been used53, 54. Most of these 
studies investigated the effect of QPLs in a cancer setting. Further research for the 
effect of QPLs on patients suffering from heart failure is still outstanding since these 
studies investigated the effect of QPLs in a cancer setting. Commented [MS8]:  The last paragraph in the following 
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Conclusions and recommendations
This review has shown that clinicians often lack disease-specific knowledge about the 
clinical management of advanced heart failure and the confidence to engage with 
EOL issues and ACP. Available evidence suggests that training clinicians should 
include skills to identify the level of a patient’s need for information, clarifying a 
patient’s care preferences and values and being able to engage a patient in a 
conversation on all available treatment options. There are a number of suggested 
methods to achieve these skills which may include interactive educational meetings 
involving role play preferably facilitated by local opinion leaders and experts in the 
field of heart failure to enhance clinicians’ engagement. 
Based on current findings, training clinicians in the delivery of ACP in heart failure 
might be equally important to assisting patients to start an ACP conversation. This 
two-fold approach may mitigate against the high emotional impact of ACP on 
healthcare professionals. Complex interventions are needed to support both, clinicians 
as well as patients, to engage with ACP in heart failure.
Commented [MS9]:  All references have been deleted from 
the conclusion and recommendation section.
Page 37 of 51
https://mc.manuscriptcentral.com/bmjspcare
BMJ Supportive & Palliative Care
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Confidential: For Review Only
16
REFERENCES
1. Connolly M, Beattie J, Walker DM. End of life care in heart failure: A 
framework for implementation; National End of Life Care Programme. 
London: 2010. 
2. Ministry of Health. Advance Care Planning. Minsitry of Health; Canberra, 
Australia: 2016.
3. McIlvennan CK, Allen LA. Palliative care in patients with heart failure. BMJ 
2016; 353. doi: 10.1136/bmj.i1010
4. Mullick A, Martin J, Sallnow L. An introduction to advance care planning in 
practice. BMJ : British Medical Journal 2013; 347. doi: 10.1136/bmj.f6064
5. National Partnership for End-of-Life Care. Ambitions for Palliative and End 
of Life Care. A national framework for local action. London: 2015.
6. Detering KM, Hancock AD, Reade MC, Silvester W. The impact of advance 
care planning on end of life care in elderly patients: randomised controlled 
trial. BMJ 2010; 340. doi: 10.1136/bmj.c1345
7. Teno JM, Gruneir A, Schwartz Z, Nanda A, Wetle T. Association between 
advance directives and quality of end-of-life care: a national study. J Am 
Geriatr Soc 2007; 55(2): 189-194. e-pub ahead of print 2007/02/17; doi: 
10.1111/j.1532-5415.2007.01045.x
8. Barnes K, Jones L, Tookman A, King M. Acceptability of an advance care 
planning interview schedule: a focus group study. Palliative medicine 2007; 
21(1): 23-28. e-pub ahead of print 2006/12/16; doi: 
10.1177/0269216306073638
9. Stuart B. The nature of heart failure as a challenge to the integration of 
palliative care services. Current Opinion in Supportive and Palliative Care 
2007; 1(4): 249-254. doi: 10.1097/SPC.0b013e3282f283b6
10. Aw D, Hayhoe B, Smajdor A, Bowker LK, Conroy SP, Myint PK. Advance 
care planning and the older patient. QJM: An International Journal of 
Medicine 2012; 105(3): 225-230. doi: 10.1093/qjmed/hcr209
Page 38 of 51
https://mc.manuscriptcentral.com/bmjspcare
BMJ Supportive & Palliative Care
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Confidential: For Review Only
17
11. Adler ED, Goldfinger JZ, Kalman J, Park ME, Meier DE. Palliative care in the 
treatment of advanced heart failure. Circulation 2009; 120(25): 2597-2606. e-
pub ahead of print 2009/12/23; doi: 10.1161/circulationaha.109.869123
12. Lund S, Richardson A, May C. Barriers to Advance Care Planning at the End 
of Life: An Explanatory Systematic Review of Implementation Studies. PLOS 
ONE 2015; 10(2): e0116629. doi: 10.1371/journal.pone.0116629
13. Barclay S, Momen N, Case-Upton S, Kuhn I, Smith E. End-of-life care 
conversations with heart failure patients: a systematic literature review and 
narrative synthesis. The British Journal of General Practice 2011; 61(582): 
e49-e62. doi: 10.3399/bjgp11X549018
14. Momen NC, Barclay SIG. Addressing 'the elephant on the table': barriers to 
end of life care conversations in heart failure - a literature review and narrative 
synthesis. Curr 2011; 5(4): 312-316. doi: 
http://dx.doi.org/10.1097/SPC.0b013e32834b8c4d
15. Slort W, Schweitzer B, Blankenstein A, Abarshi E, Riphagen I, Echteld M et 
al. Perceived barriers and facilitators for general practitioner–patient 
communication in palliative care: A systematic review. Palliative medicine 
2011; 25(6): 613-629. doi: doi:10.1177/0269216310395987
16. De Vleminck A, Pardon K, Beernaert K, Deschepper R, Houttekier D, Van 
Audenhove C et al. Barriers to advance care planning in cancer, heart failure 
and dementia patients: a focus group study on general practitioners' views and 
experiences. PLoS One 2014; 9(1): e84905. e-pub ahead of print 2014/01/28; 
doi: 10.1371/journal.pone.0084905
17. Smeets M, Van Roy S, Aertgeerts B, Vermandere M, Vaes B. Improving care 
for heart failure patients in primary care, GPs' perceptions: a qualitative 
evidence synthesis. BMJ Open 2016; 6(11): e013459. e-pub ahead of print 
2016/12/03; doi: 10.1136/bmjopen-2016-013459
18. Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative 
research (COREQ): a 32-item checklist for interviews and focus groups. 
International Journal for Quality in Health Care 2007; 19(6): 349-357. doi: 
10.1093/intqhc/mzm042
19. Tong A, Flemming K, McInnes E, Oliver S, Craig J. Enhancing transparency 
in reporting the synthesis of qualitative research: ENTREQ. BMC Med Res 
Methodol 2012; 12: 181. e-pub ahead of print 2012/11/29; doi: 10.1186/1471-
2288-12-181
Page 39 of 51
https://mc.manuscriptcentral.com/bmjspcare
BMJ Supportive & Palliative Care
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Confidential: For Review Only
18
20. Dixon-Woods M, Agarwal S, Jones D, Young B, Sutton A. Synthesising 
qualitative and quantitative evidence: a review of possible methods. J Health 
Serv Res Policy 2005; 10. doi: 10.1258/1355819052801804
21. De Vleminck A, Houttekier D, Pardon K, Deschepper R, Van Audenhove C, 
Vander Stichele R et al. Barriers and facilitators for general practitioners to 
engage in advance care planning: a systematic review. Scandinavian journal 
of primary health care 2013; 31(4): 215-226. e-pub ahead of print 2013/12/05; 
doi: 10.3109/02813432.2013.854590
22. Schickedanz AD, Schillinger D, Landefeld CS, Knight SJ, Williams BA, 
Sudore RL. A clinical framework for improving the advance care planning 
process: start with patients' self-identified barriers. J Am Geriatr Soc 2009; 
57(1): 31-39. e-pub ahead of print 2009/01/28; doi: 10.1111/j.1532-
5415.2008.02093.x
23. Doyle LH. Synthesis through meta-ethnography: paradoxes, enhancements, 
and possibilities. Qualitative Research 2003; 3(3): 321-344. doi: 
doi:10.1177/1468794103033003
24. The SURE Collaboration. Guides for Preparing and Using Evidence-Based 
Policy Briefs. SURE Collaboration. New York: World Health Organization, 
2011.
25. Oxman AD, Vandvik PO, Lavis JN, Fretheim A, Lewin S. SUPPORT Tools 
for evidence-informed health Policymaking (STP) 2: Improving how your 
organisation supports the use of research evidence to inform policymaking. 
Health Research Policy and Systems 2009; 7(1): S2. doi: 10.1186/1478-4505-
7-s1-s2
26. Granados A, Jonsson E, Banta HD, Bero L, Bonair A, Cochet C et al. EUR-
ASSESS Project Subgroup Report on Dissemination and Impact. Int J Technol 
Assess Health Care 1997; 13(2): 220-286. e-pub ahead of print 1997/04/01; 
27. Lavis J, Davies H, Oxman A, Denis JL, Golden-Biddle K, Ferlie E. Towards 
systematic reviews that inform health care management and policy-making. J 
Health Serv Res Policy 2005; 10 Suppl 1: 35-48. e-pub ahead of print 
2005/08/02; doi: 10.1258/1355819054308549
28. CASP. Critical Appraisal Skills Programme. Qualitative Appraisal Checklist 
for Qualitative Research. In: Casper ES, (ed) Qualitative Appraisal Checklist: 
CASP, 2011.
Page 40 of 51
https://mc.manuscriptcentral.com/bmjspcare
BMJ Supportive & Palliative Care
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Confidential: For Review Only
19
29. Dixon-Woods M. Using framework-based synthesis for conducting reviews of 
qualitative studies. BMC Medicine 2011; 9(1): 39. doi: 10.1186/1741-7015-9-
39
30. Noyes J, Popay J. Directly observed therapy and tuberculosis: how can a 
systematic review of qualitative research contribute to improving services? A 
qualitative meta-synthesis. Journal of Advanced Nursing 2007; 57(3): 227-
243. doi: 10.1111/j.1365-2648.2006.04092.x
31. Bloomer MJ, Morphet J, O’Connor M, Lee S, Griffiths D. Nursing care of the 
family before and after a death in the ICU—An exploratory pilot study. 
Australian Critical Care 2013; 26(1): 23-28. doi: 
http://dx.doi.org/10.1016/j.aucc.2012.01.001
32. Brooks LA, Manias E, Nicholson P. Barriers, enablers and challenges to 
initiating end-of-life care in an Australian intensive care unit context. 
Australian Critical Care 2017; 30(3): 161-166. doi: 
https://doi.org/10.1016/j.aucc.2016.08.001
33. Hayes SM, Peloquin S, Howlett JG, Harkness K, Giannetti N, Rancourt C et 
al. A qualitative study of the current state of heart failure community care in 
Canada: what can we learn for the future? BMC Health Serv Res 2015; 15: 
290. e-pub ahead of print 2015/07/29; doi: 10.1186/s12913-015-0955-4
34. Hjelmfors L, Stromberg A, Friedrichsen M, Martensson J, Jaarsma T. 
Communicating prognosis and end-of-life care to heart failure patients: a 
survey of heart failure nurses' perspectives. Eur J Cardiovasc Nurs 2014; 
13(2): 152-161. e-pub ahead of print 2014/02/01; doi: 
10.1177/1474515114521746
35. Ostertag SG, Forman WB. End-of-life care in Hancock County, Maine: a 
community snapshot. The American journal of hospice & palliative care 2008; 
25(2): 132-138. e-pub ahead of print 2008/01/17; doi: 
10.1177/1049909107310143
36. Barnes S, Gott M, Payne S, Seamark D, Parker C, Gariballa S et al. 
Communication in heart failure: perspectives from older people and primary 
care professionals. Health & social care in the community 2006; 14(6): 482-
490. e-pub ahead of print 2006/10/25; doi: 10.1111/j.1365-2524.2006.00636.x
37. Boyd KJ, Murray SA, Kendall M, Worth A, Benton TF, Clausen H. Living 
with advanced heart failure: a prospective, of patients and their carers based 
study community. European Journal of Heart Failure 2004; 6(5): 585-591. 
doi: 10.1016/j.ejheart.2003.11.018
Page 41 of 51
https://mc.manuscriptcentral.com/bmjspcare
BMJ Supportive & Palliative Care
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Confidential: For Review Only
20
38. Close H, Hancock H, Mason JM, Murphy JJ, Fuat A, de Belder M et al. "It's 
Somebody else's responsibility" - perceptions of general practitioners, heart 
failure nurses, care home staff, and residents towards heart failure diagnosis 
and management for older people in long-term care: a qualitative interview 
study. BMC geriatrics 2013; 13: 69. e-pub ahead of print 2013/07/09; doi: 
10.1186/1471-2318-13-69
39. Denvir MA, Highet G, Robertson S, Cudmore S, Reid J, Ness A et al. Future 
Care Planning for patients approaching end-of-life with advanced heart 
disease: an interview study with patients, carers and healthcare professionals 
exploring the content, rationale and design of a randomised clinical trial. BMJ 
Open 2014; 4(7). doi: 10.1136/bmjopen-2014-005021
40. Fuat A, Hungin AP, Murphy JJ. Barriers to accurate diagnosis and effective 
management of heart failure in primary care: qualitative study. BMJ 2003; 
326(7382): 196. e-pub ahead of print 2003/01/25; 
41. Glogowska M, Simmonds R, McLachlan S, Cramer H, Sanders T, Johnson R 
et al. Managing patients with heart failure: a qualitative study of 
multidisciplinary teams with specialist heart failure nurses. Ann Fam Med 
2015; 13(5): 466-471. e-pub ahead of print 2015/09/16; doi: 
10.1370/afm.1845
42. Hancock HC, Close H, Fuat A, Murphy JJ, Hungin AP, Mason JM. Barriers to 
accurate diagnosis and effective management of heart failure have not 
changed in the past 10 years: a qualitative study and national survey. BMJ 
Open 2014; 4(3): e003866. e-pub ahead of print 2014/04/03; doi: 
10.1136/bmjopen-2013-003866
43. Hanratty B, Hibbert D, Mair F, May C, Ward C, Capewell S et al. Doctors' 
perceptions of palliative care for heart failure: focus group study. BMJ 2002; 
325(7364): 581-585. 
44. Murray SA, Firth A, Schneider N, Van den Eynden B, Gomez-Batiste X, 
Brogaard T et al. Promoting palliative care in the community. Palliative 
medicine 2015; 29(2): 101-111. doi: 10.1177/0269216314545006
45. Selman L, Harding R, Beynon T, Hodson F, Coady E, Hazeldine C et al. 
Improving end-of-life care for patients with chronic heart failure: "Let's hope 
it'll get better, when I know in my heart of hearts it won't". Heart 2007; 93(8): 
963-967. e-pub ahead of print 2007/02/21; doi: 10.1136/hrt.2006.106518
46. Seymour J, Almack K, Kennedy S. Implementing advance care planning: a 
qualitative study of community nurses' views and experiences. BMC Palliative 
Care 2010; 9(1): 4. doi: 10.1186/1472-684x-9-4
Page 42 of 51
https://mc.manuscriptcentral.com/bmjspcare
BMJ Supportive & Palliative Care
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Confidential: For Review Only
21
47. Boyd KJ, Worth A, Kendall M, Pratt R, Hockley J, Denvir M et al. Making 
sure services deliver for people with advanced heart failure: a longitudinal 
qualitative study of patients, family carers, and health professionals. Palliative 
medicine 2009; 23(8): 767-776. doi: 
http://dx.doi.org/10.1177/0269216309346541
48. Selman LE, Brighton LJ, Robinson V, George R, Khan SA, Burman R et al. 
Primary care physicians' educational needs and learning preferences in end of 
life care: A focus group study in the UK. BMC Palliat Care 2017; 16(1): 17. 
e-pub ahead of print 2017/03/10; doi: 10.1186/s12904-017-0191-2
49. De Vleminck A, Pardon K, Beernaert K, Deschepper R, Van Audenhove C, 
Deliens L et al. Barriers to advance care planning in cancer, heart failure and 
dementia patients: A focus group study on general practitioners' views and 
experiences. Supportive Care in Cancer 2015; 23 (1 SUPPL. 1): S206-S207. 
50. Howlett J. Palliative care in heart failure: Addressing the largest care gap, 
vol. 26. 2011.
51. Clayton JM, Hancock K, Parker S, Butow PN, Walder S, Carrick S et al. 
Sustaining hope when communicating with terminally ill patients and their 
families: a systematic review. Psycho-oncology 2008; 17(7): 641-659. doi: 
10.1002/pon.1288
52. Hancock K, Clayton JM, Parker SM, Wal der S, Butow PN, Carrick S et al. 
Truth-telling in discussing prognosis in advanced life-limiting illnesses: a 
systematic review. Palliative medicine 2007; 21(6): 507-517. -pub ahead of 
print 2007/09/12; doi: 10.1177/0269216307080823
53. Clayton JM, Butow PN, Tattersall MH, Devine RJ, Simpson JM, Aggarwal G 
et al. Randomized controlled trial of a prompt list to help advanced cancer 
patients and their caregivers to ask questions about prognosis and end-of-life 
care. Journal of clinical oncology : official journal of the American Society of 
Clinical Oncology 2007; 25(6): 715-723. e-pub ahead of print 2007/02/20; 
doi: 10.1200/jco.2006.06.7827
54. Walczak A, Butow PN, Tattersall MHN, Davidson PM, Young J, Epstein RM 
et al. Encouraging early discussion of life expectancy and end-of-life care: A 
randomised controlled trial of a nurse-led communication support program for 
patients and caregivers. International Journal of Nursing Studies 2017; 67: 
31-40. doi: https://doi.org/10.1016/j.ijnurstu.2016.10.008
Page 43 of 51
https://mc.manuscriptcentral.com/bmjspcare
BMJ Supportive & Palliative Care
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Confidential: For Review Only
22
DECLARATIONS
Contributorship
The list of authors i cluding the main author, Markus Schichtel (MS), and the co-
authors, Bee Wee (BW), John I. MacArtney (JIM), and Sarah Collins (SC) represents 
all those who can legitimately claim authorship by making a substantial contribution.
MS had the idea for the review, wrote the protocol, extracted, evaluated and analysed 
the data, wrote, critically revised and submitted the entire manuscript. BW critically 
supervised the conduct of the review and revised the entire manuscript. JIM critically 
revised the study protocol, the narrative synthesis as well as the SURE analysis of 
barriers and facilitators. SC independently screened papers, extracted data and 
evaluated the study quality according to the CASP assessment tool. All co-authors 
approved the version to be published. 
Funding
This research and authors received no specific grant from any funding agency in the 
public, commercial, or not-for-profit sectors. 
Competing interests
The author(s) declare no potential conflicts of interest with respect to the research, 
authorship, and /or publication of this article.
Exclusive license
The Corresponding Author has the right to grant on behalf of all authors and does 
grant on behalf of all authors, an exclusive licence on  a world-wide basis to the BMJ 
Publishing Group Ltd and its Licensees to permit this article (if accepted) to be 
published in BMJ Supportive & Palliative Care editions and any other BMJJPGL 
products to exploit all subsidiary rights, as set out in our licence. 
Ethics statement
This systematic review and narrative synthesis did not require ethics approval.
Acknowledgements
We thank Nia Roberts, health science librarian, Bodleian Library, University of 
Oxford, for running the literature data base searches.
Page 44 of 51
https://mc.manuscriptcentral.com/bmjspcare
BMJ Supportive & Palliative Care
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Confidential: For Review Only
 
Figure 1 PRISMA Flow-diagram 
190x210mm (96 x 96 DPI) 
Page 45 of 51
https://mc.manuscriptcentral.com/bmjspcare
BMJ Supportive & Palliative Care
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Confidential: For Review Only
  Appendix 1. Medline Search Results
exp Heart Failure/ 107923
Heart assist devices/ or Defibrillators, Implantable/ 26004
((heart or cardiac) adj2 failure).ti,ab. 154116
((left ventric* or right ventric* or biventric*) adj2 failure).ti,ab. 6666
(hf or ahf or chf).ti,ab. 50746
((heart or ventric*) adj2 assist device?).ti,ab. 9681
(implant* adj2 (defibrillator? or cardiover*)).ti,ab. 13290
1 or 2 or 3 or 4 or 5 or 6 or 7 234634
exp Advance Care Planning/ 8297
palliative care/ or exp terminal care/ 86989
Terminally Ill/ 6154
(advance* adj2 (care plan* or directive* or statement*)).ti,ab. 5497
living will*.ti,ab. 1172
"do not resuscitate".ti,ab. 1880
"right to die".ti,ab. 903
(resuscitation adj3 (plan* or order* or wish*)).ti,ab. 458
((write or written or writing or make? or made or making) adj3 will?).ti,ab. 11747
((write or written or writing or make? or made or making) adj3 care plan*).ti,ab. 343
("end of life" adj3 (plan* or care)).ti,ab. 9586
("end of life" adj3 place*).ti,ab. 76
("end of life" adj3 (rite? or wish or wishes)).ti,ab. 199
("end of life" adj3 (home? or hospital? or hospice?)).ti,ab. 701
(palliative care or palliative therap* or palliative treat*).ti,ab. 30553
(terminal care or terminal therap* or terminal treat* or terminal* ill*).ti,ab. 7953
((death or dying) adj3 plan*).ti,ab. 1413
((death or dying or die?) adj3 place*).ti,ab. 3471
((death or dying or final) adj2 (rite? or wish or wishes)).ti,ab. 229
((death or dying or die?) adj3 (home? or hospital? or hospice?)).ti,ab. 16862
euthanasia.ti,ab. 9834
(assisted adj2 (death or dying or suicide)).ti,ab. 3558
"Tissue and Organ Procurement"/ 16159
(organ adj3 (donor* or donation)).ti,ab. 11332
9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 
or 26 or 27 or 28 or 29 or 30 or 31 or 32
165744
(barrier* or challenge* or constraint? or hinder* or hindrance or obstacl* or disempower* or 
discourag* or inequit* or inequalit*).ti,ab.
951263
(facilitat* or opportunit* or empower* or enab* or encourag* or equit* or equalit*).ti,ab. 1121477
(implement* or adopt* or transfer* or translat* or integrat* or cooperat* or co-operat* or 
coordinat* or co-ordinat* or collaborat* or tailor*).ti,ab.
2171378
34 or 35 or 36 3696141
8 and 33 and 37 867
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Appendix 2. Excluded studies
Study ID Reason for exclusion
Allen 2012 Low focus on review question; not a qualitative study; paper is an executive 
summary on decision-making in advanced heart failure
Boyd 2009 Low quality CASP score of study and focus on review question
Denvir 2015 Low focus on review question; not a qualitative study; paper describes future 
care planning and staged implementation of ACP, anticipatory care planning in 
heart failure; low focus on barriers and facilitators to the implementation of 
ACP by healthcare professionals
Detering 2014 Lack of focus on review question; paper describes the evaluation of a brief 
multimodality education programme
Gibbs 2002 Not a qualitative study; paper describes the role palliative care for patients 
living and dying from heart failure
Gibbs 2006 Survey of specialist palliative care services for heart failure; paper has a low 
focus on review objective; 
Haga 2012 Low focus on the study objective: paper describes an observational cohort of 
138 community based patients but does not focus on HCPs barriers and 
facilitators to the implementation of ACP
Hanratty 2006 Low focus on study objective: does not go into detail on barriers and facilitators 
of ACP in heart failure
Jaarsma 2009 Descriptive paper but not a qualitative study; paper is a position statement from 
the heart failure association of the European Society of Cardiology
Johnson 2006 Not a qualitative study and low focus on study objective; paper describes issues 
with palliative care service provision for heart failure
Johnson 2007 Not a qualitative study; paper describes management of end-stage heart failure; 
lack of focus on research objective
Kavalieratos 2014 Lack of focus on review objectives; aim of the paper is to characterize 
unresolved symptom and treatment needs with which heart failure patients 
present
Knauft 2005 Lack of focus on heart failure: paper looks at patients suffering from COPD
LeMond 2011 Not a qualitative study; paper describes palliative management for heart failure
LeMond 2015 Lack of focus on review question: paper describes concept on shared decision-
making but does not address in detail barriers and facilitators to ACP
McIlvennan 2016 Lack of focus on review question: focus of the paper is to describe palliative 
care for heart failure more from a clinical management point of view
Murray 2002 Low of focus on review questions: did not address barriers and facilitators to 
ACP for HCPs
Murray 2004 Lack of focus on review question: did not address barriers and facilitators to 
ACP for HCPs
Simon 2015 Paper focusses exclusively on patients, does not include the perspectives of 
HCPs on barriers and facilitators to the implementation of ACP in heart failure
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Appendix 3. SURE Framework
Level Factors affecting implementation
Knowledge and skills
Attitudes regarding programme acceptability, 
appropriateness and credibility
Recipients of care
Motivation to change or adopt new behavior
Knowledge and skills
Attitudes regarding programme acceptability, 
appropriateness and credibility
Providers of care
Motivation to change or adopt new behavior
Knowledge and skills
Attitudes regarding programme acceptability, 
appropriateness and credibility
Other stakeholders (including other healthcare providers, 
community health committees, community leaders, 
programme managers, donors, policymakers and opinion 
leaders) Motivation to change or adopt new behavior
Accessiblity of care
Financial resources
Human resources
Educational and training system, including 
recruitment and selection
Clinical supervision, support structures and 
guidelines
Internal communication
External communication
Allocation of authority
Accountability
Community participation
Management and/or leadership
Information systems
Scale of private sector care
Facilities
Patient flow processes
Procurement and distribution systems
Incentives
Bureaucracy
Health system constraints
Relationship with norms and standards
Ideology
Governance
Short-term thinking
Contracts
Legislation or regulation
Donor policies
Influential people
Corruption
Social and political constraints
Political stability and commitment
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Appendix 4. CASP Questions 
1. Was there a clear statement of the aims of the research?    Yes      Can’t tell    No     
HINT: Consider  What was the goal of the research?  Why it was thought important?  Its relevance 
2. Is a qualitative methodology appropriate?                     Yes       Can’t tell   No 
HINT: Consider  If the research seeks to interpret or illuminate the  actions and/or subjective experiences of 
research participants  Is qualitative research the right methodology for  addressing the research goal? 
Is it worth continuing?
3. Was the research design appropriate to address the  aims of the research? 
                 Yes          Can’t tell   No      
HINT: Consider  If the researcher has justified the research design  (e.g. have they discussed how they decided 
which  method to use)? 
4. Was the recruitment strategy appropriate to the aims of the      Yes         Can’t tell   No      
research? 
HINT: Consider  If the researcher has explained how the participants were selected  If they explained why 
the participants they selected were the most appropriate to provide access to the type of knowledge sought by 
the study  If there are any discussions around recruitment (e.g. why  some people chose not to take part)          
5. Was the data collected in a way that addressed research issue? 
      Yes       Can’t tell    No     the 
HINT: Consider   If the setting for data collection was justified  If it is clear how data were collected (e.g. 
focus group, semi-structured interview etc.)  If the researcher has justified the methods chosen  If the 
researcher has made the methods explicit (e.g.  for interview method, is there an indication of how  interviews 
were conducted, or did they use a topic guide)? 
6. Has the relationship between researcher and participants been adequately considered?                                   
Yes       Can’t tell    No               
HINT: Consider  If the researcher critically examined their own role, potential bias and influence during  (a) 
Formulation of the research questions (b) Data collection, including sample recruitment and choice of location 
 How the researcher responded to events during the study and whether they considered the implications of any 
changes  in the research design .
7. Have ethical issues been taken into consideration?      Yes       Can’t tell    No               
HINT: Consider  If there are sufficient details of how the research was explained to participants for the reader 
to assess whether ethical standards were maintained  If the researcher has discussed issues raised by the study 
(e.g. issues around informed consent or confidentiality or how they have handled the effects of the study on the 
participants during and after the study)  If approval has been sought from the ethics committee 
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Required amendments for paper BMJspacare-2018-
001747
Amendments were addressed by
1. Embedded Figures
 Please remove all figures from the body of the 
manuscript and re-upload your figure files 
separately.
 Please note that we do not accept figures in Word 
document, PowerPoint or PDF format.
 All figures and images should be supplied as high 
quality image files, we recommend PNG,TIFF or 
JPG/JPEG. Please ensure images are a minimum of 
300dpi and a maximum of 600dpi (resolution).
 All figures are removed from the body of the 
manuscript and uploaded separately
 The PRISMA flow-diagram is uploaded as a 
figure in TIFF format.
2. Title page
 Kindly make sure that the title page should be 
embedded at the first page of your main document
 Make sure the word count does  not exceed the 
limit and is provided on the title page
The title page is now embedded as the first page of the 
main document.
The main manuscript contains the abstract
The word count is within limits and on the title page.
3. Supplementary file / Appendix 
Please be informed that this should be in PDF Format.
The supplementary file is now in PDF format.
4. Word Count
Please make sure that the word count is provided on the title 
page. Be sure that it does not exceed the requested count.
The word count is provided on the title page.
5. Include the following statements in the main document: 
contributorship, funding, competing interests, exclusive 
license, ethics statement
These statements are now part of the main document.
6. Include a marked copy A marked copy has been included.
Reviewer 1/ Associate Editor Comments
Update your search We had updated the original literature (March 2018) 
review with result from a search in July 2018. We have 
now formally evaluated these new results. We did not 
find any additional relevant papers. The PRISMA flow 
diagram, and search results have been updated 
accordingly. 
Please choose MeSH terms for your keywords We have included heart failure, advance care planning, 
barriers, facilitators, clinicians as keywords
Methods: How would have dealt with a paper that described 
ACP for people heart failure and other life-limiting illnesses?
Studies that described ACP for people with other life-
limiting illnesses that involved heart failure were 
included in the review. The limitation of this ‘mixed’ 
study populations is now acknowledged under 
limitations in the discussion section and states:
“Some studies included other life-limiting illnesses like 
cancer or COPD in addition to patients suffering from 
heart failure. Consequently, our findings may have been 
affected by barriers and facilitators to the 
implementation of ACP that exist in other end-of-life 
conditions and not just heart failure.”
Use the original PRISMA diagram and update your results We have used the original PRISMA diagram and 
updated our results.
Reviewer 2
You reference a paper by McCarthy, Hall and Ley which was 
published in 1997. The figures cited add shock value - only 
8% of heart failure patients were told time was short but there 
must be more recent papers than this.
We have updated the reference with a more recent paper 
from Eric D. Adler , Judith Z. Goldfinger , Jill Kalman , 
Michelle E. Park , and Diane E. Meier 
et al. (2009). “Palliative Care in the Treatment of 
Advanced Heart Failure. 
https://doi.org/10.1161/CIRCULATIONAHA.109.86912
3 Circulation. 2009;120:2597–2606 
the discussion section - This repeats the findings in bullet 
point but there is little discussion and interpretation of their 
The first paragraph of the discussion section (i.e. the 
bullet points) are meant to summarise the principal 
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significance. This should be addressed before this paper can 
be published. 
findings of the literature review. While this may seem 
like a repetition of content, it is standard practice of 
starting the discussion section of a systematic review.  
We have made an effort to constructively interpret the 
significance of the findings in relation to the other 
literature. The sub-sections “Comparison with existing 
literature” in the Discussion part which compares our 
findings with that of other reviews. 
The last paragraph in the following subsection 
“Strengths and Limitations” now highlights the novelty 
of the main findings from this review compares this with 
existing literature.
All references have been deleted from the conclusion 
and recommendation section. 
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